Skip to main content

Duke Cancer Institute

DCI Blog
Events
DCI Members
Contact
Give

Cancer Types and Programs

Primary Brain Cancer
Brain and Spine Metastasis
Breast Cancer
Endocrine Neoplasia
Gastrointestinal Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematologic Malignancies and Cellular Therapy
Immunotherapy
Melanoma and Advanced Skin Cancers
Molecular Tumor Board
Oncologic Reconstructive Surgery
Pediatric Cancers
Prostate and Urologic Cancers
Sarcoma
Thoracic Cancer
Thyroid Cancer

Supportive Care

Supportive Care and Survivorship Center

Research

Cancer Registry
Clinical Trials
Research Programs
Shared Resources

Education and Training

Office of Cancer Research Training and Education Coordination

About DCI

DCI Overview
DCI Members
Nursing
Careers
Community Outreach and Engagement
Contact
DCI blog
Events

Get Involved

Giving Opportunities
Benefits and Special Events
Breakthroughs Magazine

Make an Appointment

Blogs

Recurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy

Published

January 13, 2021

Written By

Sarah Avery

Director, Duke Health News Office

Topics

Brain Cancer
Preston Robert Tisch Brain Tumor Center
Research

Share

Share This Page

Print Page Or Copy Link Url

Copied to clipboard

Related News

Good Grief

December 09, 2025

Durham Magazine

Laura Gorski

From Patient to Purpose: Laura Gorski’s Story

October 16, 2025

Duke University School of Medicine

Related News

Good Grief

December 09, 2025

Durham Magazine

Laura Gorski

From Patient to Purpose: Laura Gorski’s Story

October 16, 2025

Duke University School of Medicine

Website Privacy Policy
Sitemap
Leading with Heart: Serving Humanity
Notice of Nondiscrimination
Notice of Privacy Practices
Terms and Conditions
Accessibility
© DUKE CANCER INSTITUTE 2025

Back to Top